未登录

Y

Yonghong Zhang

capital medical university

H指数:26

被引数:4,465

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

YAP-mediated glycolysis promotes pulmonary arterial smooth muscle cells proliferation in pulmonary arterial hypertension

YAP介导的糖酵解促进肺动脉高压中的肺动脉平滑肌细胞增殖

Journal of Biological Chemistry

IF3.9

2025-10-160

OAAI

Machine Learning-Based Model for Predicting Recurrence-Free Survival After Interventional Therapy in Malnourished Hepatocellular Carcinoma Patients

基于机器学习的模型：预测营养不良肝细胞癌患者介入治疗后无复发生存期

CANCER MEDICINE

IF3.1

2025-09-140

OAAI

Association of systemic immune-inflammatory index with all-cause and cancer mortality in Americans aged 60 years and older

FRONTIERS IN AGING

IF4.3

2025-03-100

OAAI

Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study

基于机器学习的高系统免疫炎症指数肝癌患者复发预测模型的多中心研究

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-09-090

OAAI

Optimal dosage of rituximab for children with Burkitt lymphoma

ANNALS OF HEMATOLOGY

IF2.4

2023-12-131

PRE

Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC

FRONTIERS IN ONCOLOGY

IF3.3

2023-11-280

OAAI

Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy

CANCER CELL INTERNATIONAL

IF6

2023-11-192

OAAI

The Advancement of Nanomaterials for the Detection of Hepatitis B Virus and Hepatitis C Virus

纳米材料检测乙型肝炎病毒和丙型肝炎病毒的研究进展

IF4.6

2023-10-212

OAAI

Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2023-09-066

OA

Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments

FRONTIERS IN ONCOLOGY

IF3.3

2023-08-286

OAAI

Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence

IF3.4

2023-05-303

OAAI

Comparison of NK cell subsets, receptors and functions induced by radiofrequency ablation and microwave ablation in HBV-associated primary hepatocellular carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2023-05-021

OAAI

Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy

FRONTIERS IN ONCOLOGY

IF3.3

2023-03-092

OAAI

AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R

IF4.6

2022-12-084

OAAI

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-11-2365

OAAI

Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-231

OAAI

Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma

序贯不同b细胞抗原靶向CAR T细胞治疗小儿难治性/复发性伯基特淋巴瘤

IF7.1

2022-01-2729

OAAI

The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study

FRONTIERS IN ONCOLOGY

IF3.3

2021-12-169

OAAI

A CpG Methylation Signature as a Potential Marker for Early Diagnosis of Hepatocellular Carcinoma From HBV-Related Liver Disease Using Multiplex Bisulfite Sequencing

FRONTIERS IN ONCOLOGY

IF3.3

2021-10-202

OAAI

Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages

IF3.4

2021-09-0811

OAAI